Your browser doesn't support javascript.
loading
PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma.
Holst, Frederik; Werner, Henrica M J; Mjøs, Siv; Hoivik, Erling A; Kusonmano, Kanthida; Wik, Elisabeth; Berg, Anna; Birkeland, Even; Gibson, William J; Halle, Mari K; Trovik, Jone; Cherniack, Andrew D; Kalland, Karl-Henning; Mills, Gordon B; Singer, Christian F; Krakstad, Camilla; Beroukhim, Rameen; Salvesen, Helga B.
Afiliação
  • Holst F; Center for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway. mail@frederikholst.org.
  • Werner HMJ; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Mjøs S; Department of Cancer Biology and Department of Medical Oncology, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts.
  • Hoivik EA; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Kusonmano K; Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Wik E; Center for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Berg A; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Birkeland E; Center for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Gibson WJ; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Halle MK; Center for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Trovik J; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Cherniack AD; Center for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Kalland KH; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Mills GB; Computational Biology Unit, University of Bergen, Bergen, Norway.
  • Singer CF; Bioinformatics and Systems Biology Program, School of Bioresources and Technology, King Mongkut's University of Technology Thonburi, Bangkok, Thailand.
  • Krakstad C; Center for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Beroukhim R; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Salvesen HB; Department of Pathology, Haukeland University Hospital, Bergen, Norway.
Clin Cancer Res ; 25(1): 334-345, 2019 01 01.
Article em En | MEDLINE | ID: mdl-30442683
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico / Biomarcadores Tumorais / Neoplasias do Endométrio / Classe I de Fosfatidilinositol 3-Quinases Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico / Biomarcadores Tumorais / Neoplasias do Endométrio / Classe I de Fosfatidilinositol 3-Quinases Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article